Idera Pharmaceuticals reported $2.27M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US USD 2.69B 65M
Agenus AGEN:US USD 18.1M 809K
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.29B 40M
Biogen BIIB:US USD 563.3M 9.3M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Cytrx CYTR:US USD 51.91K 1.93M
Dynavax Technologies DVAX:US USD 32.04M 3.69M
Eli Lilly And LLY:US USD 1.61B 10.9M
Gilead Sciences GILD:US USD 1.21B 144M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Idera Pharmaceuticals IDRA:US USD 2.27M 391K
Merk MRK:US USD 2.47B 13M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Pfizer PFE:US USD 3.54B 345M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M